Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

A description of the content follows : How will micro cap company Bio-Matrix Scientific Group (BMSN) benefit from continued advances in cell therapies using the DNA found in adipose (fat) tissue? Here's how.

Blog Counter

Small Cap Network Blog

10/20/2008

Micro Cap Bio-Matrix (BMSN) Validated By Heart Cell Generation Breakthrough

Filed under: — SmallCapNetwork Editor @ 6:57 am

Sometimes the positive details of a particular company are clear…the company will tell them to you. When the information comes from an unbiased and unprompted media source, those positive details mean so much more. So what? We’ve spent the better part of the last few months talking about the former for micro cap stock Bio-Matrix Scientific Group (BMSN). But, recent news of an Australian biotech breakthrough - heart cell generation from DNA found in fat tissue - has indirectly confirmed the need for a company like Bio-Matrix.

If the biotechnology sound familiar, it’s because Bio-Matrix has been gearing up to store massive quantities of adipose (fat) tissue for this very purpose – the possibility of creating any sort of cell for therapeutic purposes. Since all these treatments are tailor-made for a certain patient, each of these individuals has to store their healthy DNA (via fat tissue) if they want to be able to receive the cellular therapy later in life.

The underlying messages we’re getting from the Australian announcement are (1) the technology’s development is still going forward, and (2) the benefit of said technology may help treat heart problemsone of the biggest medical problems the world is constantly facing.

Bio-Matrix Solutions’ role in all of this is simply as the storage center for these millions of fat tissue samples; someone else will be developing the demand by advancing the science.

To be clear, the ability to cultivate therapeutic cells is not new – it’s the creation of heart cells that’s the breakthrough. So, Bio-Matrix won’t have to wait years for the technology to be completed before they can derive revenue. In fact, they’re ready to bear revenue now (and are actually in cell-storage negotiations).

Our point was simply to reinforce that the biotechnology of adipose/fat tissue isn’t just a quirky project. It’s getting more and more attention, and the bigger that industry becomes, the more money Bio-Matrix can make.

Here’s the link to the heart cell breakthrough news story. It’s a video clip.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Comments »

No comments yet.

RSS feed for comments on this post.

Leave a comment

Line and paragraph breaks automatic, e-mail address never displayed, HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>